Literature DB >> 23721555

Outcomes after kidney transplantation of patients previously diagnosed with atrial fibrillation.

C R Lenihan1, M E Montez-Rath, J D Scandling, M P Turakhia, W C Winkelmayer.   

Abstract

Little is known about the prevalence and outcomes of patients with atrial fibrillation/flutter (AF) who receive a kidney transplant. We identified all patients who had >1 year of uninterrupted Medicare A+B coverage before receiving their first kidney transplant (1997-2009). The presence of pretransplant AF was ascertained from diagnosis codes in Medicare physician claims. We studied the posttransplant outcomes of death, all-cause graft failure, death-censored graft failure and stroke using multivariable Cox regression. Of 62 706 eligible first kidney transplant recipients studied, 3794 (6.4%) were diagnosed with AF prior to kidney transplant. Over a mean follow up of 4.9 years, 40.6% of AF patients and 24.9% without AF died. All-cause and death-censored graft failure were 46.8% and 16.5%, respectively, in the AF group and 36.4% and 19.5%, respectively, in those without AF. Ischemic stroke occurred in 2.8% of patients with and 1.6% of patients without AF. In patients with AF, multivariable-adjusted hazard ratios (95% confidence intervals) for death, graft failure, death-censored graft failure and ischemic stroke were 1.46 (1.38-1.54), 1.41 (1.34-1.48), 1.26 (1.15-1.37) and 1.36 (1.10-1.68), respectively. Pre-existing AF is associated with poor posttransplant outcomes. Special attention should be paid to AF in pretransplant evaluation, counseling and risk stratification of kidney transplant candidates. © Copyright 2013 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Year:  2013        PMID: 23721555      PMCID: PMC3670777          DOI: 10.1111/ajt.12197

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  35 in total

1.  Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF).

Authors:  Leif Friberg; Niklas Hammar; Hans Pettersson; Mårten Rosenqvist
Journal:  Eur Heart J       Date:  2007-08-01       Impact factor: 29.983

2.  Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.

Authors:  R A Wolfe; V B Ashby; E L Milford; A O Ojo; R E Ettenger; L Y Agodoa; P J Held; F K Port
Journal:  N Engl J Med       Date:  1999-12-02       Impact factor: 91.245

3.  Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.

Authors:  E J Benjamin; P A Wolf; R B D'Agostino; H Silbershatz; W B Kannel; D Levy
Journal:  Circulation       Date:  1998-09-08       Impact factor: 29.690

4.  Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis.

Authors:  Herwig-Ulf Meier-Kriesche; Bruce Kaplan
Journal:  Transplantation       Date:  2002-11-27       Impact factor: 4.939

5.  Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10.

Authors:  Rae A Kokotailo; Michael D Hill
Journal:  Stroke       Date:  2005-07-14       Impact factor: 7.914

6.  Caffeine and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study.

Authors:  Lars Frost; Peter Vestergaard
Journal:  Am J Clin Nutr       Date:  2005-03       Impact factor: 7.045

7.  Hospitalized atrial fibrillation after renal transplantation in the United States.

Authors:  Kevin C Abbott; Joel C Reynolds; Allen J Taylor; Lawrence Y Agodoa
Journal:  Am J Transplant       Date:  2003-04       Impact factor: 8.086

8.  The hemodynamic consequences of cardiac arrhythmias: evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model.

Authors:  M Naito; D David; E L Michelson; M Schaffenburg; L S Dreifus
Journal:  Am Heart J       Date:  1983-08       Impact factor: 4.749

9.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

Authors:  P A Wolf; R D Abbott; W B Kannel
Journal:  Stroke       Date:  1991-08       Impact factor: 7.914

Review 10.  A systematic review of kidney transplantation from expanded criteria donors.

Authors:  Julio Pascual; Javier Zamora; John D Pirsch
Journal:  Am J Kidney Dis       Date:  2008-09       Impact factor: 8.860

View more
  13 in total

1.  Addressing missing data in clinical studies of kidney diseases.

Authors:  Maria E Montez-Rath; Wolfgang C Winkelmayer; Manisha Desai
Journal:  Clin J Am Soc Nephrol       Date:  2014-02-07       Impact factor: 8.237

2.  Influence of Kidney Transplant Status on Warfarin Dose, Anticoagulation Control, and Risk of Hemorrhage.

Authors:  Megan V Yanik; Marguerite R Irvin; T Mark Beasley; Pamala A Jacobson; Bruce A Julian; Nita A Limdi
Journal:  Pharmacotherapy       Date:  2017-11-02       Impact factor: 4.705

Review 3.  Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction.

Authors:  Tatjana S Potpara; Charles J Ferro; Gregory Y H Lip
Journal:  Nat Rev Nephrol       Date:  2018-03-26       Impact factor: 28.314

Review 4.  Preoperative Noncoronary Cardiovascular Assessment and Management of Kidney Transplant Candidates.

Authors:  Jayson Rakesh Baman; Joseph Knapper; Zankhana Raval; Matthew E Harinstein; John J Friedewald; Kameswari Maganti; Michael J Cuttica; Michael I Abecassis; Ziad A Ali; Mihai Gheorghiade; James D Flaherty
Journal:  Clin J Am Soc Nephrol       Date:  2019-09-25       Impact factor: 8.237

5.  Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study.

Authors:  Wolfgang C Winkelmayer; Tara I Chang; Aya A Mitani; Emilee R Wilhelm-Leen; Victoria Ding; Glenn M Chertow; M Alan Brookhart; Benjamin A Goldstein
Journal:  Am J Kidney Dis       Date:  2015-05-02       Impact factor: 8.860

6.  Correlates and outcomes of warfarin initiation in kidney transplant recipients newly diagnosed with atrial fibrillation.

Authors:  Colin R Lenihan; Maria E Montez-Rath; Jenny I Shen; John D Scandling; Mintu P Turakhia; Tara I Chang; Wolfgang C Winkelmayer
Journal:  Nephrol Dial Transplant       Date:  2014-10-21       Impact factor: 5.992

7.  Post-Transplant Cardiovascular Disease.

Authors:  Kelly A Birdwell; Meyeon Park
Journal:  Clin J Am Soc Nephrol       Date:  2021-09-23       Impact factor: 8.237

Review 8.  Intersection of cardiovascular disease and kidney disease: atrial fibrillation.

Authors:  Nisha Bansal; Chi-yuan Hsu; Alan S Go
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-05       Impact factor: 2.894

9.  Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Mintu P Turakhia; Peter J Blankestijn; Juan-Jesus Carrero; Catherine M Clase; Rajat Deo; Charles A Herzog; Scott E Kasner; Rod S Passman; Roberto Pecoits-Filho; Holger Reinecke; Gautam R Shroff; Wojciech Zareba; Michael Cheung; David C Wheeler; Wolfgang C Winkelmayer; Christoph Wanner
Journal:  Eur Heart J       Date:  2018-06-21       Impact factor: 29.983

10.  Associations of Glycemic Control With Cardiovascular Outcomes Among US Hemodialysis Patients With Diabetes Mellitus.

Authors:  Jinnie J Rhee; Yuanchao Zheng; Maria E Montez-Rath; Tara I Chang; Wolfgang C Winkelmayer
Journal:  J Am Heart Assoc       Date:  2017-06-07       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.